 | Up a level |
Ortiz-Bruechle, N., Muders, M., Toma, M., Esposito, I, Hartmann, A., Stoehr, R., Reis, H., Wild, P., Koellermann, J., Bremmer, F., Leichsenring, J., Stenzinger, A., Merkelbach-Bruse, S., Kirfel, S., Perner, S., Hartmann, N., Roth, W., Jung, A., Kirchner, T., Schwamborn, K., Pfarr, N., Dahl, E., Knuechel, R. and Gaisa, N. T. (2020). Status of the availability and use of next generation sequencing (NGS) in bladder cancer-a questionnaire within the uropathology working group. Urologe, 59 (3). S. 318 - 326. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0563
Pfarr, N. and Merkelbach-Bruse, S. (2021). Homologous recombination repair deficiency as a predictive biomarker Basic mechanisms and detection methods. Pathologe, 42 (4). S. 391 - 399. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1963
Weichert, W., Bartels, S., Baretton, G., Braicu, E. I., Demes, M. C., Endris, V., Herold, S., Heukamp, L., Hummel, M., Lehmann, U., Merkelbach-Bruse, S., Pfarr, N., Rad, R., Sehouli, J., Siemanowski, J., Stenzinger, A., von Schwarzenberg, K., Vollbrecht, C., Wild, P. and Zocholl, D. (2021). Concordance between multiple HRD assays is substantial in high-grade ovarian cancer. Ann. Oncol., 32. S. S747 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Weichert, W., Bartels, S., Braicu, I., Christinat, Y., Demes, M., Endris, V., Herold, S., Heukamp, L. C., Hummel, M., Lehmann, U., Merkelbach-Bruse, S., Pfarr, N., Rad, R., Sehouli, J., Siemanowski, J., Stenzinger, A., von Schwarzenberg, K., Vollbrecht, C., Wild, P. J. and Zocholl, D. (2022). High concordance of different molecular assays in the determination of HRD associated GIS in high grade epithelial ovarian cancer. Ann. Oncol., 33 (7). S. S808 - 2. AMSTERDAM: ELSEVIER. ISSN 1569-8041